Tech Company CollectionsMedical Organizations
List of Medical Organizations
| Company Name | Description | Year Founded | Total Amount Raised |
|---|---|---|---|
1910 Genetics is a biotechnology company integrating AI, computation, and biological automation to improve drug development. The company establishes an understanding of the molecular basis of disease to the granularity at which the world understands sickle | 2018 | $26,650,000 | |
1UpHealth, Inc. designs and develops software. The Company offers patients, providers, and developers aggregate and share health data including information from EHRs through an API. 1UpHealth serves clients in the United States. | 2017 | $75,480,000 | |
Discover what 125+ personalized reports have to say about your ancestry, health, traits and more. | 2006 | $1,118,573,568 | |
410 Medical is a medical device company dedicated to developing innovative products that enable frontline medical providers to improve care. | 2013 | $38,249,992 | |
4d Molecular Therapeutics, LLC operates as a biotechnology company. The Company designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions. 4d Molecular Therapeutics serves customers in the State of Californ | 2013 | $295,000,000 | |
Just because you can’t see something, doesn’t mean it’s not there. 4D Path’s patented precision oncology platform is designed to unveil previously hidden data to instantly provide biomarker profiling and stratification directly from H&E whole slide biopsy/ | 2016 | $18,754,108 | |
54gene was founded in 2019 by Dr. Abasi Ene-Obong to address the significant gap in the global genomics market; Nearly 90% of genetic material used in pharmaceutical research is Caucasian. Only 2% is African, despite the fact that Africans and people of Af | 2019 | $94,725,000 | |
5Metis is a new pure-play discovery company for crop health. The company is the result of a union of Boragen and AgriMetis platforms, to combine boron-based small molecule discovery and synthetic biology for discovering new modes of action. | 2021 | $10,000,000 | |
64x Bio is transforming the future of cell and gene therapy manufacturing with high throughput discovery and design of enhanced cell lines for next-generation biomanufacturing and therapeutics. | 2017 | $59,500,000 | |
9am.health redesigns all care elements into one digital service individualized around today’s reality of people’s life - always available and convenient, at prices anyone can afford even without insurance. 9am.health focuses on chronic conditions such as d | 2021 | $19,700,000 | |
AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases. | 2020 | $107,000,000 | |
Abacus Bioscience is developing a new class of immunotherapy that unleashes the power of a novel CD180 platform technology. Our Antigen-Specific Immune Accelerants (ASIA) are POTENT, SPECIFIC and DURABLE, with broad applications across infectious disease a | 2017 | $4,413,591 | |
Abata Therapeutics, a company focused on translating the biology of regulatory T cells (Tregs) into transformational medicines for patients living with progressive multiple sclerosis (MS) and other severe autoimmune and inflammatory diseases. | 2021 | $95,000,000 | |
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both autoimmunity and cancer. They leverage the systematic target validation and clinical insights gained by its founders to identify new targets. Their intensive | 2020 | $59,849,992 | |
Able Health is the one platform physician organizations need to manage value-based programs. From calculating HEDIS and Medicare measures to engaging clinicians and health plans, managing value-based programs can take an army of administrators and IT staff | 2015 | Unknown | |
Pharmaceutical company, which developed Nuplazid, based in San Diego, California. | 1993 | $811,734,976 | |
LeukoDx, Inc. develops microflow cytometer systems for diagnostic applications. The Company provides compact table-top flow cytometry instruments based on microfluidics technology, as well as products are used for applications ranging from early sepsis det | 2007 | $19,500,000 | |
AccessHope believes in putting the ever-growing body of cancer knowledge to work for the greater good. The company delivers a revolutionary employee health benefit that connects cancer patients and their families with expertise from a National Cancer Insti | 2019 | Unknown | |
Access Physicians is a multispecialty physician group that provides inpatient telemedicine. Each day, countless Americans go without the care they need due to an inability to access a physician. Access Physicians seeks to systematically improve and regiona | 2020 | $9,675,000 | |
Acenxion Biosystems (ACXBIO) is a privately funded company developing automated systems for bacteria detection in blood cultures and phenotypic antimicrobial susceptibility testing (AST). Seamlessly fitting into current clinical workflows, Acenxion’s scala | 2020 | $4,254,000 | |
Acepodia is using its proprietary bioconjugation technology to develop the next wave of off-the-shelf cell therapies for cancer. | 2016 | $256,000,000 | |
Acolyte health creates automated interactive video content featuring the caregiver’s digital twin to deliver a more effective call-to-action instructional video, in multiple languages, for the 70% of patients that don’t understand their treatment plan or w | 2022 | $1,241,500 | |
ActiveHealth Management is a national leader in population health management and passionate about helping every person achieve his or her best health. They deliver personalized guidance through their analytics and insights, care management, health, lifesty | 2020 | $2,000,000 | |
Activ Surgical is a digital surgery company focused on improving surgical efficiency, accuracy, patient outcomes, and accessibility. Its scalable and patent-protected surgical software platform technology is driven by computer vision, artificial intelligen | 2017 | $100,400,040 | |
Activate Care is a nationally-recognized provider of community coordination and referral management technology designed to improve community health outcomes. Hundreds of healthcare and social services organizations across the country use the Activate CareH | 2012 | $8,400,000 | |
AcuityMD provides a platform for commercializing and improving medical devices with data. The platform brings clarity to the products used to treat patients, helping medical device companies expand access in their markets. | 2019 | $38,000,000 | |
Adagio Medical, Inc. is a privately held company located in Laguna Hills, California developing innovative cryoablation technologies that create continuous, linear, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial | 2011 | $65,640,112 | |
Adagio Therapeutics is developing best-in-class antibodies that can broadly neutralize SARS-CoV-2, SARS-CoV-1, and additional potentially emergent coronaviruses. They believe that antibodies will match or exceed the potency and coverage of conventional SAR | 2020 | $466,000,000 | |
Adcentrx is a biotechnology company focused on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases. By combining the targeting precision of biologics and the disease fighting power of small | 2021 | $88,000,000 | |
Adela’s mission is to develop innovative and accessible technologies that harness biology and change the way we diagnose and treat disease. Adela’s genome-wide methylation enrichment technology was originally developed by Chief Scientific Officer Dr. Danie | 2020 | $88,031,992 | |
Adicet Bio, Inc. operates as a clinical-stage bio-pharmaceutical company. The Company designs and develops of off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet Bio serves customers worldwide. | 2016 | $145,624,992 | |
Adtech is an innovative biotech firm that has developed a novel formulation of a sole-sourced synthetic cannabinoid therapeutic targeting glaucoma. The company was founded in 2021 and is based in Warwick, Rhode Island, United States. | 2021 | $5,982,000 | |
Advanced Diabetes Supply provides diabetes testing supplies to people nationwide. Our highly trained staff and state of the art technology ensures fast and convenient home delivery anywhere in the country. | 2002 | Unknown | |
We create nanoparticle technologies that enable and improve drug uptake and retention into the cell for medical devices. | 2018 | $16,500,000 | |
Ummet clinical need: According to a 2017 FDA safety notification, the failure (of surgical navigation systems) to adequately track changes in the position of patient anatomy during surgery (''intra-operative shift'') has led to “patient deaths, serious a | 2017 | $12,295,006 | |
Adverum Biotechnologies, formerly known as Avalanche Biotechnologies, is a publicly traded (NASDAQ:ADVM) clinical stage gene therapy company located in Redwood City, California. The company is targeting unmet medical needs for serious ocular and rare disea | 2006 | $637,372,608 | |
Adyn is a precision medicine company that develops personalized birth control methods. It provides medically actionable scientific insights and empowers individuals to proactively optimize their health—from birth control to fertility and beyond. The compan | 2019 | $2,625,000 | |
Adze Biotechnology is a pre-clinical stage company that develops oncolytic immunotherapies for the treatment of cancers. It has exclusive licenses to oncolytic immunotherapies developed in the lab of Dr. Michael Barry of Mayo Clinic. The company was founde | 2019 | $6,149,998 | |
Aera was founded with a vision to unlock the potential of genetic medicines across a broad range of modalities and therapeutic areas. Our protein nanoparticle (PNP) delivery platform leverages the discovery of endogenous, human proteins that can self-assem | 2021 | $193,000,000 | |
Aethon Therapeutics treats cancer by combining immunotherapy and targeted treatment to increase its effectiveness. Aethon's unique anti-drug-peptide conjugate/MHC antibodies are intended to be employed in conjunction with TCI of RAS, EGFR, and other cancer | 2022 | $30,000,000 | |
AEYE Health’s AI tech instantly diagnoses a large variety of conditions from retinal images and helps prevent blindness and save lives. The company's FDA-approved broad screening solution can detect a variety of medical conditions, prevent blindness and sa | 2018 | $10,000,000 | |
AgroSpheres develops novel technologies that aim to set a new standard for bio-based delivery of active ingredients. It uses a unique platform technology for crop protection solutions and other industrial applications. The company is an encapsulation and d | 2016 | $38,102,744 | |
Airvet believes that pet care should extend beyond the walls of an office to support your pet's health wherever you are. | 2018 | $32,200,000 | |
AIRx Health is a financial services company. | Unknown | ||
AIxMed helps pathologists to digitize 3D cytology samples in minutes and extract clinical insights in seconds. The company was founded in 2018 and is headquartered in Santa Clara, California, United States. | 2018 | $11,019,972 | |
Akerna (Nasdaq: KERN) is an enterprise software company focused on compliantly serving the cannabis, hemp, and CBD industries. Based in Denver, Colorado, the Company's mission is to create the world's most transparent and accountable supply chain by buildi | 2010 | $77,200,000 | |
Akoya Biosciences, Inc. operates as a biotechnology company. The Company offers end-to-end solutions for high-parameter tissue analysis from discovery through clinical and translational research, enabling the development of more precise therapies for immun | 2015 | $127,000,000 | |
Akros Medical is a developer of innovative solutions for orthopedic surgeons. The company was founded in 2014 and is headquartered in Durham, NC | 2020 | $1,060,000 | |
Alara’s mission is to continuously optimize patient health and care delivery through medical imaging and data-driven analytics. | 2020 | $6,125,000 | |
A-LIGN is a technology-enabled security and compliance partner that helps global organizations take a strategic approach to confidently mitigate cybersecurity risks. Our breadth and depth of expertise and A-SCEND, our proprietary compliance management plat | 2009 | $136,000,000 | |
Alignment Healthcare Partners LP provides healthcare services. The Company offers health management, research, and advisory services to hospitals. Alignment Healthcare Partners operates in the United States. | 2013 | $375,000,000 | |
Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of viral infections and liver diseases. Aligos is focused on the development of targeted antiviral t | 2018 | $396,900,000 | |
AliveCor, Inc. develops electrocardiogram recorders. The Company creates credit card-sized wireless devices that can turn mobile platforms into heart monitors. AliveCor serves clients worldwide. | 2010 | $154,284,896 | |
Allakos Inc. operates as a clinical stage bio-technology company. The Company discovers and develops therapeutic antibodies for the treatment of allergic, inflammatory, and proliferative diseases. Allakos serves customers in the United States. | 2012 | $312,449,536 | |
Alleviate designs self-treatment systems for chronic pathologies, combining digital and physical technologies sold direct-to-consumer. It offers a complete, holistic recovery system to help people self-manage foot pain from heel pain, plantar fasciitis (PF | 2020 | $3,579,273 | |
Allogene Therapeutics, Inc. operates as a biotechnology company. The Company develops allogeneic chimeric antigen receptor T-cell therapy for the treatment of blood cancers and solid tumors. Allogene Therapeutics serves patients in the State of California. | 2017 | $651,770,368 | |
Alloplex Biotherapeutics is dedicated to exploring the higher order combinatorial space of immunomodulators to develop an effective anti-tumor vaccine. This approach is applicable to all tumor types and is particularly suited to combinations with checkpoin | 2016 | $21,200,000 | |
Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. Through a community of partners, we democratize access to tools, technologies, services, and company creation capabilities | 2017 | $128,250,000 | |
Alphabet Inc. operates as a holding company. The Company, through its subsidiaries, provides web-based search, advertisements, maps, software applications, mobile operating systems, consumer content, enterprise solutions, commerce, and hardware products. | 2015 | Unknown | |
Alpha is a new healthcare services company developing a technology platform designed to enable easy, personalized access to online diagnosis and prescription treatment for some of the most common illnesses today. We’re backed by investment from Data Collec | 2017 | $35,000,000 | |
Alpha Source, Inc (DBA Alpha Isotopes) is an early stage company that has developed a new technology to create radioisotopes. This patented technology will not only allow the Company to produce widely used radioisotopes at a significantly lower cost than | 2013 | Unknown | |
Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers. Alpheus Medical also provides a non-invasive drug-device combination for outpatient treatment of recurrent glioblastoma multiforme (rGBM). | 2021 | $30,000,000 | |
Alpine Immune Sciences, Inc. (AIS) focuses on developing novel protein-based cancer immunotherapies using its proprietary variant ig domain (vIgD) platform technology. The Company develops TIP technology, based on the vIgD platform, to enhance engineered c | 2015 | $325,300,000 | |
Alsana eating recovery centers provide innovative, client-focused and evidence-based eating disorder treatment in residential, partial hospitalization and intensive-outpatient settings. Alsana's world-renowned clinical leaders are committed to providing yo | 1988 | Unknown | |
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions. It is currently focused on finding curative therapies for fibrosis, NASH, and liver cancer. It develops novel small mol | 2019 | $3,235,000 | |
Alterome Therapeutics is a precision oncology biotech developing alteration-specific therapeutics to address high value and validated oncogenic drivers. | 2021 | $99,000,000 | |
Alterwood Health is a managed care company that provides healthcare services to its members and providers. They promote strong doctor-patient relationships through supportive care management strategies, innovative technology, and attractive reimbursement m | 2020 | $10,445,000 | |
Altesa is a clinical-stage biopharmaceutical company dedicated to accelerating the development of new treatments against age-old threats to human health: high-consequence viral pathogens. | 2022 | $35,000,000 | |
ScriptDash Inc., doing business as Alto pharmacy, operates as a pharmacy. The Company offers online prescribed medicines. Alto pharmacy serves customers in the State of California. | 2015 | $560,030,016 | |
Altos Labs, Inc. is an American biotechnology research company. Altos Labs' goal is to develop life extension therapies that can halt or reverse the human aging process. Specialized cell therapies based on induced pluripotent stem cells are to be developed | 2022 | $3,000,000,000 | |
AltruBio is a privately held biotechnology company headquartered in the San Francisco Bay Area that is focused on developing novel antibody therapeutics for the treatment of immunological diseases with high unmet medical needs. | 2020 | $102,610,000 | |
Alucent Biomedical is a biomedical company that develops a combination drug-device therapy called Natural Vascular Scaffolding (NVS) for the treatment of vascular diseases. NVS is a first-of-a-kind combination drug-device therapy designed to assist the bod | 2017 | $46,600,000 | |
The mission of Alume Biosciences is to make its proprietary nerve illumination technology available for surgeons so that patients everywhere can benefit. | 2017 | $27,672,024 | |
Alzheon is an American clinical-stage biopharmaceutical company based in Framingham, Massachusetts. The company is developing medicines for patients suffering from Alzheimer's disease and other neurological and psychiatric disorders. | 2013 | $138,154,880 | |
AmbAgon Therapeutics is a developer of cancer molecule therapeutics. The company offers research of a small molecule that augments a tumor-suppressing protein. AmbAgon Therapeutics was founded by Christian Ottmann, Lucas Brunsveld, and Michelle Arkin. | 2020 | $148,000,000 | |
Ambra Health is a medical data and image management SaaS company. Intuitive, flexible, scalable and highly interoperable, the Ambra cloud platform is designed to serve as the backbone of imaging innovation and progress for healthcare providers. It empowers | 2004 | $47,284,136 | |
Ambrx, Inc. operates as a biopharmaceutical company. The Company develops therapeutics such as long acting proteins, bi-specifics, and antibody drug conjugates. Ambrx operates in worldwide. | 2003 | $500,948,992 | |
American Injectables is a sterile injectable manufacturer of parenteral drugs with a world-class facility focused on ready-to-use pre-filled syringes and vials. | 2020 | $10,000,000 | |
Amplicore develops injectable and minimally invasive therapeutics for musculoskeletal disorders. | 2019 | $4,000,000 | |
AmplifyBio is a biotechnology company that develops next-generation cell and gene therapies. The company's mission is to create pathways for novel treatment advances, cutting-edge technologies, and new research frontiers to advance medical breakthroughs, t | 2021 | $230,000,000 | |
Amplyx Pharmaceuticals, Inc. operates as a small molecule drug development company. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. | 2006 | $198,370,000 | |
Amunix Inc. is a pharmaceutical company. The Company focuses on therapeutic drugs which offer an alternative to antibodies and small molecules. Amunix also concentrates on protein design and the discovery research process. | 2006 | $190,000,000 | |
Amuse is an e-commerce cannabis delivery business that is reinventing the way consumers order and consume cannabis. We’re a team of bright, driven, and experienced e-commerce operators from companies including Amazon, Bird, Eaze, Nike, MedMen, Target, Weed | 2020 | $23,000,000 | |
Amwell, formerly known as American Well, is a telemedicine company based in Boston, Massachusetts, that connects patients with doctors over secure video. Amwell sells its platform as a subscription service to healthcare providers to put their medical profe | 2006 | $865,954,112 | |
Amydis is a privately-held pharmaceutical company focused on developing innovative chemistry to detect diseases that involve the presence of amyloid proteins. | 2013 | $16,185,723 | |
Ananya Health develops a medical device to treat cervical pre-cancer in the highest-burden regions of the world. | 2020 | $125,000 | |
ANA Therapeutics is a developer of a novel coronavirus vaccine intended to save human lives. It is developing therapeutics to solve the coronavirus pandemic using Niclosamide that enables medical practitioners to treat patients suffering from COVID-19. It | 2020 | $5,000,000 | |
Anavasi Diagnostics is a medical technology company that focuses on the development of molecular diagnostic testing. | 2021 | $23,500,000 | |
Ancora Biotech LLC is a privately held company supporting the clinical development of three multi-specific antibodies. These three antibodies are held in separate spin-offs, namely: 1) TeneoTwo holds our clinical stage TNB-486 (anti-CD19xCD3) T cell engage | 2021 | $60,000,000 | |
AndHealth helps people reverse chronic diseases. The company operates a virtual center of excellence for migraine and is soon launching others for autoimmune conditions, including rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn’s disease. An | 2021 | $57,000,000 | |
For over 17 years, Angel Medical Systems has been committed to advancing life-sustaining patient care and the long-term management of High-Risk Coronary Artery Disease through innovation, clinical science, and collaboration. Angel Medical Systems, Inc. has | 2001 | $81,859,616 | |
Anja Health provides wellness and fitness services. | 2021 | $4,500,000 | |
Ansa Biotechnologies is developing a new way to make DNA that will be faster, cleaner, and more accurate than existing methods. Currently, DNA is manufactured via a chemical method that has remained mostly unchanged for 35 years. Our enzyme-based approach | 2018 | $83,419,680 | |
The M&B team comes from a belief that every person is born with the fundamental right to receive proper medical treatment. We work day in and day out to make this a reality. We do it by creating the first AI based digital health provider the 30 million un | 2020 | $43,000,000 | |
Antiva Biosciences, Inc. is a clinical stage biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. They aim to stop cancer before it starts by treating the pre-cancerous lesions caused by HP | 2012 | $140,346,016 | |
Aperiam Bio partners with enzyme engineers and distributors to create and share stabilized, solubilized, and catalytically optimized proteins. The company was founded in 2021 and is headquartered in Austin, Texas, United States. | 2021 | $3,660,002 | |
Apero Health is a tech-focused medical billing company that gives greater control to practices and patients about their medical payments. | 2019 | $150,000 | |
Apogee Therapeutics, Inc. is a biotechnology company advancing novel therapies to address patients’ needs. Based in San Francisco and backed by leading life sciences funds, the company expects its lead pipeline program to enter clinical trials in 2023. | 2022 | $169,000,000 | |
Apollo Medical Holdings, Inc. is a physician-centric, technology-powered, and risk-bearing healthcare management company. The Company offers a health management and healthcare delivery platform to empower the providers in its network to deliver the quality | 2001 | $334,355,808 | |
Dermatology consultation + prescription medication. Without leaving your home.
More convenient.
More affordable.
More effective.
Learn more at Apostrophe.com | 2012 | $6,125,000 |
Page 1 of 15